Aneurysm Clip Market
Aneurysm Clip Market Analysis by Titanium Alloy Clips and Cobalt-chromium Clips for Hospitals, Cardiac Centers, Specialty Clinics, and Research Centers from 2024 to 2034
Analysis of Aneurysm Clip Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Aneurysm Clip Market Outlook (2024 to 2034)
The global aneurysm clip market size is estimated at US$ 23.9 million in 2024 and is projected to reach a size of US$ 26.3 million by 2034, expanding at a low-value CAGR of 1% over the next 10 years.
Within the medical device industry, the global market has emerged as a dynamic and quickly evolving area. Aneurysms, characterized by bulging or weakening blood vessel walls, are a major public health problem around the world due to their potential to cause life-threatening illnesses such as strokes or hemorrhages.
The market, a vital component of the medical device industry, acts as a beacon of hope for patients suffering from the silent threat of intracranial aneurysms and a testament to neurosurgery's never-ending drive for innovation. Medical technology advancements, combined with increased patient awareness and significant investments in healthcare infrastructure, have collectively driven market growth, offering advanced treatment solutions and brighter prospects for both patients and healthcare professionals.
Key Market Growth Drivers
- Aneurysm clip technology has advanced significantly, with the creation of next-generation, minimally invasive clips that reduce surgical risks and enhance patient outcomes. As both surgeons and patients seek safer and more effective treatment choices, these innovations are fueling market expansion.
- Aneurysms are a common health concern, and their prevalence is rising due to a variety of variables, including aging populations and lifestyle-related risk factors. The increasing number of patients necessitates higher investment in treatment alternatives.
- Aneurysms are frequently silent threats that can be devastating if left untreated. More individuals are seeking early diagnosis and treatment as a result of increased awareness campaigns and patient education efforts, generating a larger patient pool for the aneurysm clip business.
- Private healthcare institutions and medical device businesses are aggressively investing in R&D, resulting in the launch of novel aneurysm clips with superior outcomes.
Technological innovations have played an essential role in reshaping the market, resulting in major improvements in patient outcomes and surgical procedures. These advancements have ushered in a new era of treatment precision and safety.
| Report Attributes | Details |
|---|---|
| Aneurysm Clip Market Size (2023A) | US$ 23.66 Million |
| Estimated Market Value (2024E) | US$ 23.9 Million |
| Forecasted Market Value (2034F) | US$ 26.3 Million |
| Global Market Growth Rate (2024 to 2034) | 1% CAGR |
| East Asia Market Growth Rate (2024 to 2034) | 1% CAGR |
| North America Aneurysm Clip Market Share (2034F) | 35.9% |
| Saccular Aneurysm Segment Share (2024E) | 90.2% |
| Titanium Alloy Segment Growth Rate (2024 to 2034) | 1% CAGR |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving the Sales Growth of Aneurysm Clips?
“Smoking and Hypertension Contributing to Rising Incidence of Aneurysm”
Aneurysms are no longer a rare medical condition; millions of people worldwide suffer from them. Several causes, including an aging global population, contribute to the increased occurrence. Smoking and hypertension, for example, are also substantial risk factors. The modern, frequently fast-paced style of life can promote stress-related disorders, which can contribute to the development of aneurysms.
Advancements in healthcare infrastructure and diagnostic capabilities have allowed for more accurate and prompt detection of aneurysms, resulting in a greater reported incidence. This rising pool of patients in need of treatment has naturally boosted demand for aneurysm clips as a vital component in the surgical management of this condition. The increasing incidence not only underscores the current market potential but also predicts sustained growth as demographic and lifestyle factors persist. This positions aneurysm treatment as a crucial and continually expanding subject.
“Rising Awareness of Risks Associated with Untreated Aneurysms”
Aneurysms are known as "silent killers" because they can develop with no symptoms until they rupture, often leading to fatal results such as strokes or hemorrhages. However, growing educational and public awareness campaigns have highlighted the importance of early detection and intervention. With more people becoming aware of the dangers of untreated aneurysms, there has been a paradigm shift in how patients and healthcare practitioners address these illnesses.
People are now seeking medical attention proactively for symptoms that may be related to aneurysms, as well as undergoing preventive testing if they have risk factors. This increased awareness has resulted in a significant increase in the number of patients seeking early diagnosis and treatment, resulting in a thriving market for aneurysm clips, which play an important role in securing aneurysms during surgical intervention. The emphasis on early intervention not only improves patient outcomes but also supports the aneurysm clip market growth.
What are the Hindrances Limiting the Sales of the Aneurysms Clips?
“Rigorous Regulatory Approval Procedure”
The medical device business is subject to stringent laws and quality requirements to ensure the safety and efficacy of products such as aneurysm clips. These requirements, imposed by health authorities like as the FDA in the United States or the European Medicines Agency (EMA), necessitate extensive testing, documentation, and rigorous clinical trials, extending the development and licensing process in both time and cost.
Navigating the regulatory framework necessitates a high level of skill and resources. It can be difficult for start-ups and even established businesses to keep up with changing legislation and requirements. Furthermore, meeting tight regulatory criteria frequently necessitates a large financial expenditure. The costs of preclinical and clinical investigations, quality management systems, and employing regulatory specialists can put a strain on a start-up's financial resources.
The difficult regulatory clearance procedure is a significant impediment to the aneurysm clip industry because of the several standards, the need for specialized expertise, the unpredictable delays, and the financial burden it imposes on enterprises, particularly start-ups.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Start-ups Penetrating the Global Market?
“Focus on Developing Aneurysm Clips with Greater Biocompatibility”
Start-ups should concentrate on developing cutting-edge technology and solutions that answer unmet market demands. This could include developing aneurysm clips with greater biocompatibility, convenience of use, or innovative materials that lower the risk of issues while providing a competitive advantage. It is critical to navigate the complex regulatory landscape efficiently.
Strategic partnerships with established medical device businesses and healthcare institutions provide crucial resources to start-ups, such as distribution channels, investment, and mentorship. Exploring markets in emerging regions with growing healthcare infrastructure can be a wise decision for businesses. These areas frequently have fewer established competitors and have access to a growing patient base, thus allowing for market expansion.
Country-wise Insights
The aneurysm clip market exhibits variation by nation, influenced by differences in healthcare infrastructure, awareness levels, and healthcare expenditure. Because of rising healthcare expenditure and awareness, the United States, for example, has a well-developed market.
Japan and European countries with expanding elderly populations have also emerged as lucrative markets for players. Expanding healthcare infrastructure and increased patient awareness are driving market expansion in emerging nations in Asia and Latin America.
How are Aneurysm Clip Manufacturers Faring in the United States?
“Advanced Healthcare Infrastructure and Favorable Regulatory Environment”
| Attribute | United States |
|---|---|
| Market Value (2024) | US$ 6 Million |
| Demand Growth (2024 to 2034) | 1.3% |
| Projected Value (2034) | US$ 6.87 Million |
The United States has a strong healthcare infrastructure, which includes cutting-edge medical facilities, a well-trained workforce, and an emphasis on innovation. The healthcare ecosystem in the United States includes prominent hospitals, research institutions, and medical device businesses, and serves as a hotbed for research and development, fostering the continual improvement of aneurysm clip technology.
The country has a substantial level of knowledge regarding aneurysms and the associated risks. Because of this increasing awareness, more people are seeking early diagnosis and treatments, creating a sizable market for aneurysm clips. The availability of comprehensive health insurance systems and accessible healthcare services encourages patients to address aneurysm-related concerns as soon as possible.
Government assistance and regulatory bodies play an important role in creating a favorable environment for the aneurysm clip market in the United States. The regulatory system in place in the country promotes patient safety and product efficacy, instilling trust in both healthcare professionals and patients. Furthermore, regulatory clarity speeds up the clearance process for breakthrough aneurysm clip solutions, allowing them to enter the market sooner.
Why is China at the Forefront of the Global Market?
“Partnerships with Local Healthcare Institutions and Research Institutes”
| Attribute | China |
|---|---|
| Market Value (2024) | US$ 2 Million |
| Demand Growth (2024 to 2034) | 1.2% |
| Projected Value (2034) | US$ 2.14 Million |
Significant population in China, characterized by a growing aging demographic, is contributing to a rise in aneurysm cases. China's healthcare infrastructure is expanding rapidly, thanks to major investments in advanced medical facilities, equipment, and a growing cadre of competent medical professionals.
China's emphasis on R&D, supported by both public and private investments, has propelled the country to the forefront of medical innovation. This emphasis on cutting-edge technologies and therapies has paved the way for advances in aneurysm clip technology, which has resulted in safer and more successful treatment alternatives. Chinese medical device manufacturers play a crucial role in these advancements, leading to the development of high-quality and cost-effective aneurysm clips.
The government's dedication to universal healthcare coverage, which ensures that a bigger section of the population has access to treatment, strengthens China's position in the worldwide aneurysm clip market. The country's burgeoning middle class is more health-conscious, with a greater understanding of the risks connected with untreated aneurysms. This encourages people to seek early diagnosis and treatment, leading to market expansion.
Due to the size and diversity of China's medical device market, multinational medical device companies are encouraged to build a strong presence in the country.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Material is Widely Used in the Production of Aneurysm Clips?
“High Use of Titanium Due to its High Mechanical Strength, Biocompatibility, and Durability”
| Attribute | Titanium Alloy |
|---|---|
| Market Value (2024) | US$ 19 Million |
| Demand Growth (2024 to 2034) | 1% |
| Projected Value (2034) | US$ 21 Million |
Titanium alloys have a unique set of qualities that make them ideal for the production of aneurysm clips. This supremacy of this segment can be attributed to its biocompatibility, mechanical strength, longevity, and non-reactive nature, all of which are important considerations in aneurysm clip success.
Biocompatibility is crucial in aneurysm clip applications because it ensures that the clips can be implanted safely for long periods without adverse reactions or inflammatory responses. Aneurysm clips are used to lock delicate blood arteries, and they must be strong enough to achieve a solid closure while causing no injury. Titanium alloys are known for their great tensile strength and resilience, which allows them to endure the mechanical pressures exerted on them during surgical procedures and afterward.
Titanium alloys are very corrosion-resistant, assuring the clips' lifespan without degradation or weakening caused by external influences or bodily fluids. Furthermore, the lightweight nature of titanium alloys enables ease of handling during surgical operations, minimizing the burden on surgeons and improving precision during clip placement. Manipulation ease is especially significant in delicate neurosurgery operations where precision is critical.
Competitive Landscape
Presence of well-established competitors with a global footprint and comprehensive product portfolios characterizes the competitive landscape of aneurysm clips. To preserve their competitive advantage, top companies in aneurysm clips invest extensively in R&D to consistently innovate and deliver new, superior aneurysm clip technologies to market. This advancement enables them to meet the changing needs of healthcare professionals and patients, with an emphasis on enhancing the safety and efficacy of aneurysm treatment.
- MicroVention introduced a novel aneurysm clip composed of nitinol alloy in 2023. This new clip is more robust than older aneurysm clips, and it is less prone to induce corrosion.
- Balt Extrusions introduced a new aneurysm clip delivery system in 2022 that employs robotic technology to apply aneurysm clips with improved precision. This innovative system is expected to lower the likelihood of surgical complications.
- In 2021, Medtronic introduced a novel aneurysm clip design featuring multiple arms that can be positioned around the aneurysm, providing a more secure attachment. This innovative design is anticipated to be more effective in preventing aneurysm rupture.
Segmentation of Aneurysm Clip Market Research
-
By Material Type :
- Titanium Alloy
- Cobalt-chromium Alloy
-
By Aneurysm Type :
- Cerebral
- Thoracic
- Abdominal
- Peripheral
-
By Aneurysm Indication :
- Saccular Aneurysm
- Fusiform Aneurysm
-
By Disease Indication :
- Tumor & Brain Cancer
- Brain Arteriovenous Malformations
- Ischemic Stroke
- Brain Aneurysm
-
By End User :
- Hospitals
- Cardiac Centers
- Specialty Clinics
- Research Centers
- Others
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Material Type Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Rise in Expenditure 4.1.2. Increased Per Capita Expenditure 4.2. Forecast Factors - Relevance & Impact 4.2.1. Material Type in Pipeline 4.2.2. Regulatory Scenario 4.2.3. Mergers and Acquisitions 4.2.4. Collaborative Agreements 4.2.5. Value Chain 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 4.4. COVID19 Crisis Analysis 4.4.1. Current COVID19 Statistics and Probable Future Impact 4.4.2. Current GDP Projection and Probable Impact 4.4.3. Current Economic Projection as Compared to 2008 Economic analysis 4.4.4. COVID19 and Impact Analysis 4.4.4.1. Revenue By Material Type 4.4.4.2. Revenue By Aneurysm Indication 4.4.4.3. Revenue By Aneurysm Type 4.4.4.4. Revenue By Disease Indication 4.4.4.5. Revenue By End User 4.4.4.6. Revenue By Country 4.4.5. 2020 Market Scenario 4.4.6. Quarter by Quarter Forecast 4.4.7. Projected Recovery Quarter 4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact 5. Market Context 5.1. Adoption and Usage Analysis 5.2. Market Evolution 5.3. Material Type Vs Aneurysm Indication Matrix 5.4. Regulatory Scenario 5.5. Parent Market Analysis 5.6. Key Promotional Strategies by Market Players 6. Global Market - Pricing Analysis 6.1. Regional Pricing Analysis By Material Type 6.2. Pricing Break-up 6.2.1. Manufacturer Level Pricing 6.2.2. Distributor Level Pricing 6.3. Global Average Pricing Analysis Benchmark 7. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034 7.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 7.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type 8.1. Introduction / Key Findings 8.2. Historical Market Disease Indication (US$ Mn) Analysis By Material Type, 2018 to 2023 8.3. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Material Type, 2024 to 2034 8.3.1. Titanium Alloy 8.3.2. Cobalt-chromium Alloy 8.4. Market Attractiveness Analysis By Material Type 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Aneurysm Type 9.1. Introduction / Key Findings Aneurysm Type Disease Indication, 2018 to 2023 9.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Aneurysm Type, 2024 to 2034 9.2.1. Cerebral 9.2.2. Thoracic 9.2.3. Abdominal 9.2.4. Peripheral 9.3. Market Attractiveness Analysis By Aneurysm Type 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Aneurysm Indication 10.1. Introduction / Key Findings Aneurysm Indication Disease Indication, 2018 to 2023 10.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Aneurysm Indication, 2024 to 2034 10.2.1. Saccular Aneurysm 10.2.2. Fusiform Aneurysm 10.3. Market Attractiveness Analysis By Aneurysm Indication 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Disease Indication 11.1. Introduction / Key Findings Disease Indication, 2018 to 2023 11.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Disease Indication, 2024 to 2034 11.2.1. Tumor & Brain Cancer 11.2.2. Brain Arteriovenous Malformations 11.2.3. Ischemic Stroke 11.2.4. Brain Aneurysm 11.3. Market Attractiveness Analysis By Disease Indication 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Disease Indication (US$ Mn) Analysis By End User, 2018 to 2023 12.3. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By End User, 2024 to 2034 12.3.1. Hospitals 12.3.2. Cardiac Centers 12.3.3. Specialty Clinics 12.3.4. Research Centers 12.3.5. Others 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 13.1. Introduction 13.2. Historical Market Disease Indication (US$ Mn) Analysis By Region, 2018 to 2023 13.3. Current Market Disease Indication (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. United States 14.3.1.2. Canada 14.3.2. By Material Type 14.3.3. By Aneurysm Type 14.3.4. By Aneurysm Indication 14.3.5. By Disease Indication 14.3.6. By End User 14.4. Market Attractiveness Analysis 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. United Kingdom 15.3.1.5. Spain 15.3.1.6. Rest of Europe 15.3.2. By Material Type 15.3.3. By Aneurysm Type 15.3.4. By Aneurysm Indication 15.3.5. By Disease Indication 15.3.6. By End User 15.4. Market Attractiveness Analysis 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 16.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. GCC Countries 16.3.1.2. South Africa 16.3.1.3. Rest of Middle East and Africa 16.3.2. By Material Type 16.3.3. By Aneurysm Type 16.3.4. By Aneurysm Indication 16.3.5. By Disease Indication 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. Rest of the World Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 17.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Material Type 17.3.2. By Aneurysm Type 17.3.3. By Aneurysm Indication 17.3.4. By Disease Indication 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. United States Market Analysis 18.2.1. By Material Type 18.2.2. By Aneurysm Type 18.2.3. By Aneurysm Indication 18.2.4. By Disease Indication 18.2.5. By End User 18.3. Canada Market Analysis 18.3.1. By Material Type 18.3.2. By Aneurysm Type 18.3.3. By Aneurysm Indication 18.3.4. By Disease Indication 18.3.5. By End User 18.4. United Kingdom Market Analysis 18.4.1. By Material Type 18.4.2. By Aneurysm Type 18.4.3. By Aneurysm Indication 18.4.4. By Disease Indication 18.4.5. By End User 18.5. Germany Market Analysis 18.5.1. By Material Type 18.5.2. By Aneurysm Type 18.5.3. By Aneurysm Indication 18.5.4. By Disease Indication 18.5.5. By End User 18.6. France Market Analysis 18.6.1. By Material Type 18.6.2. By Aneurysm Type 18.6.3. By Aneurysm Indication 18.6.4. By Disease Indication 18.6.5. By End User 18.7. Italy Market Analysis 18.7.1. By Material Type 18.7.2. By Aneurysm Type 18.7.3. By Aneurysm Indication 18.7.4. By Disease Indication 18.7.5. By End User 18.8. Spain Market Analysis 18.8.1. By Material Type 18.8.2. By Aneurysm Type 18.8.3. By Aneurysm Indication 18.8.4. By Disease Indication 18.8.5. By End User 18.8.6. By End User 18.9. GCC Countries Market Analysis 18.9.1. By Material Type 18.9.2. By Aneurysm Type 18.9.3. By Aneurysm Indication 18.9.4. By Disease Indication 18.9.5. By End User 18.10. South Africa Market Analysis 18.10.1. By Material Type 18.10.2. By Aneurysm Type 18.10.3. By Aneurysm Indication 18.10.4. By Disease Indication 18.10.5. By End User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Material Type foot print by Players 19.4.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. B. Braun Melsungen AG 20.3.1.1. Overview 20.3.1.2. Material Type Portfolio 20.3.1.3. Analyst Commentary 20.3.1.4. Key Financials 20.3.1.5. Recent Developments 20.3.1.6. Sales Footprint 20.3.1.7. Strategy Overview 20.3.1.7.1. Marketing Strategy 20.3.1.7.2. Material Type Strategy 20.3.1.7.3. Channel Strategy 20.3.2. Peter LAZIC GmbH 20.3.2.1. Overview 20.3.2.2. Material Type Portfolio 20.3.2.3. Analyst Commentary 20.3.2.4. Key Financials 20.3.2.5. Recent Developments 20.3.2.6. Sales Footprint 20.3.2.7. Strategy Overview 20.3.2.7.1. Marketing Strategy 20.3.2.7.2. Material Type Strategy 20.3.2.7.3. Channel Strategy 20.3.3. KLS Martin Group 20.3.3.1. Overview 20.3.3.2. Material Type Portfolio 20.3.3.3. Analyst Commentary 20.3.3.4. Key Financials 20.3.3.5. Recent Developments 20.3.3.6. Sales Footprint 20.3.3.7. Strategy Overview 20.3.3.7.1. Marketing Strategy 20.3.3.7.2. Material Type Strategy 20.3.3.7.3. Channel Strategy 20.3.4. Adeor Medical AG 20.3.4.1. Overview 20.3.4.2. Material Type Portfolio 20.3.4.3. Analyst Commentary 20.3.4.4. Key Financials 20.3.4.5. Recent Developments 20.3.4.6. Sales Footprint 20.3.4.7. Strategy Overview 20.3.4.7.1. Marketing Strategy 20.3.4.7.2. Material Type Strategy 20.3.4.7.3. Channel Strategy 20.3.5. Rebstock Instruments GmbH 20.3.5.1. Overview 20.3.5.2. Material Type Portfolio 20.3.5.3. Analyst Commentary 20.3.5.4. Key Financials 20.3.5.5. Recent Developments 20.3.5.6. Sales Footprint 20.3.5.7. Strategy Overview 20.3.5.7.1. Marketing Strategy 20.3.5.7.2. Material Type Strategy 20.3.5.7.3. Channel Strategy 20.3.6. Mizuho America 20.3.6.1. Overview 20.3.6.2. Material Type Portfolio 20.3.6.3. Analyst Commentary 20.3.6.4. Key Financials 20.3.6.5. Recent Developments 20.3.6.6. Sales Footprint 20.3.6.7. Strategy Overview 20.3.6.7.1. Marketing Strategy 20.3.6.7.2. Material Type Strategy 20.3.6.7.3. Channel Strategy 20.3.7. Stryker Corporation 20.3.7.1. Overview 20.3.7.2. Material Type Portfolio 20.3.7.3. Analyst Commentary 20.3.7.4. Key Financials 20.3.7.5. Recent Developments 20.3.7.6. Sales Footprint 20.3.7.7. Strategy Overview 20.3.7.7.1. Marketing Strategy 20.3.7.7.2. Material Type Strategy 20.3.7.7.3. Channel Strategy 20.3.8. RauMedic 20.3.8.1. Overview 20.3.8.2. Material Type Portfolio 20.3.8.3. Analyst Commentary 20.3.8.4. Key Financials 20.3.8.5. Recent Developments 20.3.8.6. Sales Footprint 20.3.8.7. Strategy Overview 20.3.8.7.1. Marketing Strategy 20.3.8.7.2. Material Type Strategy 20.3.8.7.3. Channel Strategy 20.3.9. InoMed 20.3.9.1. Overview 20.3.9.2. Material Type Portfolio 20.3.9.3. Analyst Commentary 20.3.9.4. Key Financials 20.3.9.5. Recent Developments 20.3.9.6. Sales Footprint 20.3.9.7. Strategy Overview 20.3.9.7.1. Marketing Strategy 20.3.9.7.2. Material Type Strategy 20.3.9.7.3. Channel Strategy 20.3.10. Codman & Shurtleff 20.3.10.1. Overview 20.3.10.2. Material Type Portfolio 20.3.10.3. Analyst Commentary 20.3.10.4. Key Financials 20.3.10.5. Recent Developments 20.3.10.6. Sales Footprint 20.3.10.7. Strategy Overview 20.3.10.7.1. Marketing Strategy 20.3.10.7.2. Material Type Strategy 20.3.10.7.3. Channel Strategy 20.3.11. evonos GmbH & Co. KG 20.3.11.1. Overview 20.3.11.2. Material Type Portfolio 20.3.11.3. Analyst Commentary 20.3.11.4. Key Financials 20.3.11.5. Recent Developments 20.3.11.6. Sales Footprint 20.3.11.7. Strategy Overview 20.3.11.7.1. Marketing Strategy 20.3.11.7.2. Material Type Strategy 20.3.11.7.3. Channel Strategy 20.3.12. Integra LifeSciences 20.3.12.1. Overview 20.3.12.2. Material Type Portfolio 20.3.12.3. Analyst Commentary 20.3.12.4. Key Financials 20.3.12.5. Recent Developments 20.3.12.6. Sales Footprint 20.3.12.7. Strategy Overview 20.3.12.7.1. Marketing Strategy 20.3.12.7.2. Material Type Strategy 20.3.12.7.3. Channel Strategy 20.3.13. Boston Scientific 20.3.13.1. Overview 20.3.13.2. Material Type Portfolio 20.3.13.3. Analyst Commentary 20.3.13.4. Key Financials 20.3.13.5. Recent Developments 20.3.13.6. Sales Footprint 20.3.13.7. Strategy Overview 20.3.13.7.1. Marketing Strategy 20.3.13.7.2. Material Type Strategy 20.3.13.7.3. Channel Strategy 20.3.14. Medtronic 20.3.14.1. Overview 20.3.14.2. Material Type Portfolio 20.3.14.3. Analyst Commentary 20.3.14.4. Key Financials 20.3.14.5. Recent Developments 20.3.14.6. Sales Footprint 20.3.14.7. Strategy Overview 20.3.14.7.1. Marketing Strategy 20.3.14.7.2. Material Type Strategy 20.3.14.7.3. Channel Strategy 20.3.15. Abbott 20.3.15.1. Overview 20.3.15.2. Material Type Portfolio 20.3.15.3. Analyst Commentary 20.3.15.4. Key Financials 20.3.15.5. Recent Developments 20.3.15.6. Sales Footprint 20.3.15.7. Strategy Overview 20.3.15.7.1. Marketing Strategy 20.3.15.7.2. Material Type Strategy 20.3.15.7.3. Channel Strategy 20.3.16. Ortho-Medical GmbH 20.3.16.1. Overview 20.3.16.2. Material Type Portfolio 20.3.16.3. Analyst Commentary 20.3.16.4. Key Financials 20.3.16.5. Recent Developments 20.3.16.6. Sales Footprint 20.3.16.7. Strategy Overview 20.3.16.7.1. Marketing Strategy 20.3.16.7.2. Material Type Strategy 20.3.16.7.3. Channel Strategy 20.3.17. MicroVention 20.3.17.1. Overview 20.3.17.2. Material Type Portfolio 20.3.17.3. Analyst Commentary 20.3.17.4. Key Financials 20.3.17.5. Recent Developments 20.3.17.6. Sales Footprint 20.3.17.7. Strategy Overview 20.3.17.7.1. Marketing Strategy 20.3.17.7.2. Material Type Strategy 20.3.17.7.3. Channel Strategy 20.3.18. Balt Extrusion 20.3.18.1. Overview 20.3.18.2. Material Type Portfolio 20.3.18.3. Analyst Commentary 20.3.18.4. Key Financials 20.3.18.5. Recent Developments 20.3.18.6. Sales Footprint 20.3.18.7. Strategy Overview 20.3.18.7.1. Marketing Strategy 20.3.18.7.2. Material Type Strategy 20.3.18.7.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 02: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 03: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 04: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 05: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 06: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication Age Group
Table 07: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
Table 08: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 10: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 11: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 12: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 13: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 14: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 16: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 17: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 18: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 19: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 20: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 22: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 23: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 24: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 25: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 26: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 27: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 28: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 29: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 30: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 02: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 03: Global Market Share Analysis (%), By Material Type, 2024 & 2034
Figure 04: Global Market Y-o-Y Analysis (%), By Material Type, 2024 to 2034
Figure 05: Global Market Attractiveness Analysis By Material Type, 2024 to 2034
Figure 06: Global Market Share Analysis (%), By Aneurysm Type, 2024 & 2034
Figure 07: Global Market Y-o-Y Analysis (%), By Aneurysm Type, 2024 to 2034
Figure 08: Global Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 09: Global Market Share Analysis (%), By Aneurysm Indication, 2024 & 2034
Figure 10: Global Market Y-o-Y Analysis (%), By Aneurysm Indication, 2024 to 2034
Figure 11: Global Market Attractiveness Analysis By Aneurysm Indication, 2024 to 2034
Figure 12: Global Market Share Analysis (%), By Disease Indication, 2024 & 2034
Figure 13: Global Market Y-o-Y Analysis (%), By Disease Indication, 2024 to 2034
Figure 14: Global Market Attractiveness Analysis By Disease Indication, 2024 to 2034
Figure 15: Global Market Share Analysis (%), By End User, 2024 & 2034
Figure 16: Global Market Y-o-Y Analysis (%), By End User , 2024 to 2034
Figure 17: Global Market Attractiveness Analysis, By End User, 2024 to 2034
Figure 18: Global Market Share Analysis (%), By Disease Indication Age Group, 2024 & 2034
Figure 19: Global Market Y-o-Y Analysis (%), By Disease Indication Age Group, 2024 to 2034
Figure 20: Global Market Attractiveness Analysis By Disease Indication Age Group, 2024 to 2034
Figure 21: Global Market Share Analysis (%), By Region, 2024 & 2034
Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 23: Global Market Attractiveness Analysis, By Region, 2024 to 2034
Figure 24: North America Market Value Share, By Material Type, 2024 (E)
Figure 25: North America Market Value Share, By Aneurysm Indications 2024 (E)
Figure 26: North America Market Value Share, By Aneurysm Type, 2024 (E)
Figure 27: North America Market Value Share, By Disease Indication, 2024 (E)
Figure 28: North America Market Value Share, By End User, 2024 (E)
Figure 29: North America Market Value Share, By Country, 2024 (E)
Figure 30: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 31: North America Market Attractiveness Analysis By Material Type, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis By Aneurysm Indication, 2024 to 2034
Figure 33: North America Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 34: North America Market Attractiveness Analysis By Disease Indication, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis By End User, 2024 to 2034
Figure 36: North America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 37: Europe Market Value Share, By Material Type, 2024 (E)
Figure 38: Europe Market Value Share, By Aneurysm Indications 2024 (E)
Figure 39: Europe Market Value Share, By Aneurysm Type, 2024 (E)
Figure 40: Europe Market Value Share, By Disease Indication, 2024 (E)
Figure 41: Europe Market Value Share, By End User, 2024 (E)
Figure 42: Europe Market Value Share, By Country, 2024 (E)
Figure 43: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 44: Europe Market Attractiveness Analysis By Material Type, 2024 to 2034
Figure 45: Europe Market Attractiveness Analysis By Aneurysm Indication, 2024 to 2034
Figure 46: Europe Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 47: Europe Market Attractiveness Analysis By Disease Indication, 2024 to 2034
Figure 48: Europe Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 49: Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 50: Middle East and Africa Market Value Share, By Material Type, 2024 (E)
Figure 51: Middle East and Africa Market Value Share, By Aneurysm Indication, 2024 (E)
Figure 52: Middle East and Africa Market Value Share, By Aneurysm Type, 2024 (E)
Figure 53: Middle East and Africa Market Value Share, By Disease Indication, 2024 (E)
Figure 54: Middle East and Africa Market Value Share, By End User, 2024 (E)
Figure 55: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 57: Middle East and Africa Market Attractiveness Analysis By Material Type, 2024 to 2034
Figure 58: Middle East and Africa Market Attractiveness Analysis By Aneurysm Indication, 2024 to 2034
Figure 59: Middle East and Africa Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 60: Middle East and Africa Market Attractiveness Analysis By Disease Indication, 2024 to 2034
Figure 61: Middle East and Africa Market Attractiveness Analysis By End User, 2024 to 2034
Figure 62: Middle East and Africa Market Attractiveness Analysis By Country, 2024 to 2034
Figure 63: Rest of the World Market Value Share, By Material Type, 2024 (E)
Figure 64: Rest of the World Market Value Share, By Aneurysm Indications 2024 (E)
Figure 65: Rest of the World Market Value Share, By Aneurysm Type, 2024 (E)
Figure 66: Rest of the World Market Value Share, By Disease Indication, 2024 (E)
Figure 67: Rest of the World Market Value Share, By End User, 2024 (E)
Figure 68: Rest of the World Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 69: Rest of the World Market Attractiveness Analysis By Material Type, 2024 to 2034
Figure 70: Rest of the World Market Attractiveness Analysis By Aneurysm Indication, 2024 to 2034
Figure 71: Rest of the World Market Attractiveness Analysis By Aneurysm Type, 2024 to 2034
Figure 72: Rest of the World Aneurysm Clip Market Attractiveness Analysis By Disease Indication, 2024 to 2034
Figure 73: Rest of the World Market Attractiveness Analysis By End User, 2024 to 2034
Figure 74: United States Market Value Share, By Material Type, 2024 & 2034
Figure 75: United States Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 76: United States Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 77: United States Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 78: United States Market Value Share, By End User, 2024 & 2034
Figure 79: United States Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Canada Market Value Share, By Material Type, 2024 & 2034
Figure 81: Canada Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 82: Canada Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 83: Canada Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 84: Canada Market Value Share, By End User, 2024 & 2034
Figure 85: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: United Kingdom Market Value Share, By Material Type, 2024 & 2034
Figure 87: United Kingdom Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 88: United Kingdom Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 89: United Kingdom Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 90: United Kingdom Market Value Share, By End User, 2024 & 2034
Figure 91: United Kingdom Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: Germany Market Value Share, By Material Type, 2024 & 2034
Figure 93: Germany Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 94: Germany Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 95: Germany Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 96: Germany Market Value Share, By End User, 2024 & 2034
Figure 97: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: France Market Value Share, By Material Type, 2024 & 2034
Figure 99: France Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 100: France Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 101: France. Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 102: France Market Value Share, By End User, 2024 & 2034
Figure 103: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: Italy Market Value Share, By Material Type, 2024 & 2034
Figure 105: Italy Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 106: Italy Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 107: Italy Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 108: Italy Market Value Share, By End User, 2024 & 2034
Figure 109: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: Spain Market Value Share, By Material Type, 2024 & 2034
Figure 111: Spain Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 112: Spain Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 113: Spain Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 114: Spain Market Value Share, By End User, 2024 & 2034
Figure 115: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: GCC Countries. Market Value Share, By Material Type, 2024 & 2034
Figure 117: GCC Countries Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 118: GCC Countries Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 119: GCC Countries Market Value Share, By Disease Indication, 2024 & 2034
Figure 120: GCC Countries Market Value Share, By End User, 2024 & 2034
Figure 121: GCC Countries Aneurysm Clip Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: South Africa Market Value Share, By Material Type, 2024 & 2034
Figure 123: South Africa Market Value Share, By Aneurysm Indication, 2024 & 2034
Figure 124: South Africa Market Value Share, By Aneurysm Type, 2024 & 2034
Figure 125: South Africa Market Value Share, By Disease Indication Age Group, 2024 & 2034
Figure 126: South Africa Aneurysm Clip Market Value Share, By End User, 2024 & 2034
Figure 127: South Africa Aneurysm Clip Market Value Analysis (US$ Mn), 2024 & 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the sales value of aneurysm clips in 2024?
Worldwide sales of aneurysm clips are estimated at US$ 23.9 million in 2024.
Which segment of the aneurysm clip market is predicted to account for a leading share?
Based on indication, saccular aneurysm clips predicted to hold 90.2% market share in 2024.
What is the demand forecast for aneurysm clips by 2034?
Demand for aneurysm clips is forecasted to reach a market value of US$ 26.3 million by 2034-end.
What is the sales growth projection for aneurysm clips?
Sales of aneurysm clips are projected to rise at a CAGR of 1% through 2034.
At what rate is the East Asia market predicted to grow?
The East Asia market is forecasted to expand at a CAGR of 1% over the forecast period.
Aneurysm Clip Market